The MarketWatch News Department was not involved in the creation of this content.-- Newly discovered drug leverages the power of Pattern Discovery Engine(TM) (PDE) and is an exten ...

Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat me signals" found in cancer cells heightens the immune response and ...

Despite decades of advancements in surgical techniques, chemotherapy, and radiotherapy, the clinical outlook for patients diagnosed with primary brain tumors remains sobering. Whi ...

Renowned cancer researcher Professor Richard Scolyer has shared an emotional update on his brain cancer, as he continues to ...

Massey Comprehensive Center has debuted a new first-in-market brachytherapy brain tumor surgery to treat glioblastoma, ...

False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a ...

Honing in on four markers for effective, patient-specific devices to combat glioblastoma.

The deputy chief, who retired in 2023 after nearly 30 years with the department, underwent three brain surgeries.

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs.

Telix has resubmitted the NDA with the additional data requested by the FDA. The Company believes, based on the Type A meeting and ongoing consultation with the FDA, that the additional data and ...

The ex-Oldham MP Phil Woolas battled brain cancer for more than a year, his family says.

Mass General Brigham received a $50 million anonymous donation to advance gene and cell therapy for cancer and other diseases ...